Literature DB >> 11169803

MR-guided percutaneous cryotherapy of the liver: in vivo evaluation with histologic correlation in an animal model.

J Tacke1, G Adam, P Haage, B Sellhaus, S Grosskortenhaus, R W Günther.   

Abstract

The purpose of this study was to evaluate the feasibility of MR-guided percutaneous cryotherapy of the porcine liver and to correlate the resulting tissue necrosis with MR imaging and histology. Using an MR-compatible, argon-based cryotherapy system (CryoHit; Galil Medical Ltd., Israel) with 2- and 3-mm diameter tapered cryotherapy probes, MR-guided percutaneous cryotherapy was performed in seven pigs (mean body weight, 40 kg) under general anesthesia in a short-bore magnet (1.5 T ACS NT; Philips, The Netherlands) using an ultrafast T2-weighted single-shot LoLo TSE sequence and a T1-weighted gradient-echo sequence. The frozen liver tissue was depicted accurately on fast T2- and T1-weighted sequences, providing precise delineation of the ablated tissue volume. On follow-up postcontrast MR controls, the cryolesions appeared avascular. They decreased in size compared with the initially frozen volume down to 70% at a 2-week follow-up. Histologically, a coagulation necrosis with a close correlation to the MR follow-up examinations was objectified. No cryotherapy-related complications occurred. J. Magn. Reson. Imaging 2001;13:50-56. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11169803     DOI: 10.1002/1522-2586(200101)13:1<50::aid-jmri1008>3.0.co;2-a

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  14 in total

1.  Thermal ablation for unresectable liver tumours, time to move forward?

Authors:  Gianpiero Gravante
Journal:  World J Gastrointest Surg       Date:  2010-01-27

Review 2.  MR-guided microwave ablation for malignancies.

Authors:  Yoshimasa Kurumi; Tohru Tani; Shigeyuki Naka; Hisanori Shiomi; Tomoharu Shimizu; Hajime Abe; Yoshihiro Endo; Shigehiro Morikawa
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

3.  MRI-compatible manipulator with remote-center-of-motion control.

Authors:  Nobuhiko Hata; Junichi Tokuda; Shelley Hurwitz; Shigehiro Morikawa
Journal:  J Magn Reson Imaging       Date:  2008-05       Impact factor: 4.813

4.  Combined magnetic resonance imaging and optical surgical navigation system guidance of percutaneous liver cryoablation in a porcine model.

Authors:  Kang Zhou; Zhuoli Zhang; Matteo Figini; Junjie Shangguan; Yining Wang; Haifeng Shi; Yumei Li; Zhengyu Jin; Jie Pan
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 5.  Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Abdom Radiol (NY)       Date:  2016-05

6.  Correction of susceptibility-induced GRE phase shift for accurate PRFS thermometry proximal to cryoablation iceball.

Authors:  Antje Kickhefel; Clifford Weiss; Joerg Roland; Patrick Gross; Fritz Schick; Rares Salomir
Journal:  MAGMA       Date:  2011-09-04       Impact factor: 2.310

7.  [Cryoablation - back again?].

Authors:  P Isfort; T Penzkofer; A H Mahnken
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

8.  Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up.

Authors:  Kristin A Kinsman; Mariah L White; Lance A Mynderse; Akira Kawashima; Karen Rampton; Krzysztof R Gorny; Thomas D Atwell; Joel P Felmlee; Matthew R Callstrom; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2017-10-17       Impact factor: 2.740

Review 9.  Experimental cryosurgery investigations in vivo.

Authors:  A A Gage; J M Baust; J G Baust
Journal:  Cryobiology       Date:  2009-10-13       Impact factor: 2.487

Review 10.  Magnetic Resonance-Guided Prostate Ablation.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Semin Intervent Radiol       Date:  2019-12-02       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.